Marban Linda 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Marban Linda
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-03$1.39/sh+25,000$34,750→ 223,604 total - Other
Common Stock
2025-03-05−12,500→ 211,104 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03−25,000→ 0 totalExercise: $1.39Exp: 2025-03-03→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Transferred to reporting person's ex-spouse pursuant to settlement in divorce proceeding.
- [F2]This option was granted on March 3, 2015 and was previously covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F3]Shares vested 1/48th on the first day of each month commencing April 1, 2015.